Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond

Pirfenidone (PFD) slows the progression of idiopathic pulmonary fibrosis (IPF) by inhibiting the exaggerated fibrotic response and possibly through additional mechanisms, such as anti-inflammatory effects. PFD has also been evaluated in other fibrosing lung diseases. Myocardial fibrosis is a common...

Descripción completa

Detalles Bibliográficos
Autores principales: Aimo, Alberto, Spitaleri, Giosafat, Nieri, Dario, Tavanti, Laura Maria, Meschi, Claudia, Panichella, Giorgia, Lupón, Josep, Pistelli, Francesco, Carrozzi, Laura, Bayes-Genis, Antoni, Emdin, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2022
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062707/
https://www.ncbi.nlm.nih.gov/pubmed/35516794
http://dx.doi.org/10.15420/cfr.2021.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062707/
https://www.ncbi.nlm.nih.gov/pubmed/35516794
http://dx.doi.org/10.15420/cfr.2021.30

Ejemplares similares